The 2nd International Conference on Gliomatosis Cerebri was held in Washington D.C on June 22nd and 23rd, 2017. It was held at the National Institutes of Health, Bethesda and was attended by leading scientists, doctors and clinicians from many of the top institutions in the US and Europe. The number of Foundations attending this year also doubled from the last event two years ago. The focus of the discussion amongst the professionals was to come to a common understanding on the nature of Gliomatosis Cerebri and to define whether it was a disease or a manifestation of certain brain tumors. it was encouraging to note that the tissue samples available had increased substantially over the last two years. There was also agreement on sharing the data between the scientists across geographies to facilitate more efficient research. The Foundations deliberated on the governance structure to get visibility on the various research activities in institutions that were being funded by them. It was also agreed that GC Global website will be developed into a single point of reference for Foundations to connect with each other, in addition to their individual websites. The main purpose of GC Global is to disseminate information about the disease and keep updating the progress made on the research. Overall a lot of headway was made at the conference and in conclusion it was agreed to focus on three important tasks, before the next conference, two years later. These are - Tissues and Targets, Immunology and Clinical Translation. Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22–23, 2017, Bethesda, USA Read more
Commenti